Avoro Capital Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Avoro Capital Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,235,000	Closed	-$115M	–	45
2021 Q4	$115M	Sell	1,235,000 -2,190,000	-64%	-$144M	1.95%	16
2021 Q3	$204M	Sell	3,425,000 -650,000	-16%	-$38.4M	3.2%	9
2021 Q2	$278M	Buy	4,075,000 +25,000	+0.6%	+$1.63M	4.83%	6
2021 Q1	$281M	Sell	4,050,000 -140,000	-3%	-$10.8M	4.85%	6
2020 Q4	$322M	Buy	4,190,000 +1,090,000	+35%	+$81.7M	5.54%	5
2020 Q3	$232M	Buy	3,100,000 +2,150,000	+226%	+$143M	3.29%	9
2020 Q2	$59.8M	Buy	+950,000	New	+$52.3M	1.18%	21

Avoro Capital Advisors's ARNA Position: Q1 2022 in Review

Avoro Capital Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 1,235,000 shares — an estimated $115M sold.

Avoro Capital Advisors first reported a position in ARNA in Q2 2020 and held it in 7 quarters. The position peaked at $322M in Q4 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Avoro Capital Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Avoro Capital Advisors sold 1,235,000 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $115M.
Avoro Capital Advisors first reported a position in Arena Pharmaceuticals Inc in Q2 2020 and held it in 7 quarters.
Avoro Capital Advisors's Arena Pharmaceuticals Inc position peaked at $322M in Q4 2020.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Avoro Capital Advisors's 13F filing for Q1 2022, filed 16 May 2022.